The Biotage® V-10 Touch at Sumitomo Dainippon Pharma
Genome Science Research Institute, Genome Science Research Department 1, Screening Group
Showing all posts
Genome Science Research Institute, Genome Science Research Department 1, Screening Group
Figure 1: PeptiDream Inc. relocated their head office in August 2017 and established its new research centre in the Kawasaki City International Strategic Centre. The expanded facility is expected to s...
Capture, purify and enrich in as little as 15 minutes to obtain high concentrations of fully functional protein. Process small sample volumes in a reproducible, high throughput, automated format. Elut...
In the search for better anti-doping testing methods The only equine drug testing laboratory in Japan, the Laboratory of Racing Chemistry (LRC) established in 1965 is an internationally accredited hor...
In this interview Mr. Akutagawa, Executive Director and Mr. Oi, Ph.D., Senior Manager of the Kashima Manufacturing and Quality Technology Department at Eisai, share their experiences with the testing ...
In 2021, Biotage acquired ATDBio, a world leader in custom oligonucleotides. Gene therapy startup Eleven Therapeutics have a close collaboration with ATDBio. We sat down with their CEO Prof. Yaniv Erl...
Environmental laboratories require a system which is clean, reliable, and affordable to evaporate the extracts resulting from the preparation of samples for PFAS testing. This document will outline a ...
The absence of impurities in peptides, synthesized via SPPS, is vital for reliable assay results. However, especially in drug discovery screenings (number of peptides > 24), potentially low-purity cru...
Moving from laboratory-scale purification to commercial production should not require starting over. A scalable approach built on consistent media and predictable methods helps you maintain performanc...
Introduction The U.S. EPA has been regulating semi-volatile organic compounds in drinking water with Method 525 since 1988. There have been several method updates since then, but the most recent was i...